279 related articles for article (PubMed ID: 28131418)
21. The pseudogene derived long noncoding RNA DUXAP8 promotes gastric cancer cell proliferation and migration via epigenetically silencing PLEKHO1 expression.
Ma HW; Xie M; Sun M; Chen TY; Jin RR; Ma TS; Chen QN; Zhang EB; He XZ; De W; Zhang ZH
Oncotarget; 2017 Aug; 8(32):52211-52224. PubMed ID: 28881724
[TBL] [Abstract][Full Text] [Related]
22. Overexpressed pseudogenes, DUXAP8 and DUXAP9, promote growth of renal cell carcinoma and serve as unfavorable prognostic biomarkers.
Chen J; Lou W; Ding B; Wang X
Aging (Albany NY); 2019 Aug; 11(15):5666-5688. PubMed ID: 31409759
[TBL] [Abstract][Full Text] [Related]
23. EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis.
Liu H; Li W; Yu X; Gao F; Duan Z; Ma X; Tan S; Yuan Y; Liu L; Wang J; Zhou X; Yang Y
Oncotarget; 2016 Aug; 7(35):56338-56354. PubMed ID: 27472460
[TBL] [Abstract][Full Text] [Related]
24. EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition.
Sun M; Liu XH; Lu KH; Nie FQ; Xia R; Kong R; Yang JS; Xu TP; Liu YW; Zou YF; Lu BB; Yin R; Zhang EB; Xu L; De W; Wang ZX
Cell Death Dis; 2014 Jun; 5(6):e1298. PubMed ID: 24967960
[TBL] [Abstract][Full Text] [Related]
25. LncRNA DUXAP8 induces breast cancer radioresistance by modulating the PI3K/AKT/mTOR pathway and the EZH2-E-cadherin/RHOB pathway.
Lei C; Li S; Fan Y; Hua L; Pan Q; Li Y; Long Z; Yang R
Cancer Biol Ther; 2022 Dec; 23(1):1-13. PubMed ID: 36329030
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of pseudogene DUXAP8 expression in glioma suppresses tumor cell proliferation.
Zhao X; Hao S; Wang M; Xing D; Wang C
Oncol Lett; 2019 Mar; 17(3):3511-3516. PubMed ID: 30867791
[TBL] [Abstract][Full Text] [Related]
27. P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression.
Zhang EB; Yin DD; Sun M; Kong R; Liu XH; You LH; Han L; Xia R; Wang KM; Yang JS; De W; Shu YQ; Wang ZX
Cell Death Dis; 2014 May; 5(5):e1243. PubMed ID: 24853421
[TBL] [Abstract][Full Text] [Related]
28. Over-expression of LSD1 promotes proliferation, migration and invasion in non-small cell lung cancer.
Lv T; Yuan D; Miao X; Lv Y; Zhan P; Shen X; Song Y
PLoS One; 2012; 7(4):e35065. PubMed ID: 22493729
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA SNHG17 is an unfavourable prognostic factor and promotes cell proliferation by epigenetically silencing P57 in colorectal cancer.
Ma Z; Gu S; Song M; Yan C; Hui B; Ji H; Wang J; Zhang J; Wang K; Zhao Q
Mol Biosyst; 2017 Oct; 13(11):2350-2361. PubMed ID: 28933484
[TBL] [Abstract][Full Text] [Related]
30. Integrative profiling analysis identifies the oncogenic long noncoding RNA DUXAP8 in oral cancer.
Chen M; Zheng Y; Xie J; Zhen E; Zhou X
Anticancer Drugs; 2020 Sep; 31(8):792-798. PubMed ID: 32304409
[TBL] [Abstract][Full Text] [Related]
31. EZH2 promotes malignant behaviors via cell cycle dysregulation and its mRNA level associates with prognosis of patient with non-small cell lung cancer.
Cao W; Ribeiro Rde O; Liu D; Saintigny P; Xia R; Xue Y; Lin R; Mao L; Ren H
PLoS One; 2012; 7(12):e52984. PubMed ID: 23300840
[TBL] [Abstract][Full Text] [Related]
32. SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma.
Xu Y; Yao Y; Jiang X; Zhong X; Wang Z; Li C; Kang P; Leng K; Ji D; Li Z; Huang L; Qin W; Cui Y
J Exp Clin Cancer Res; 2018 Apr; 37(1):81. PubMed ID: 29642935
[TBL] [Abstract][Full Text] [Related]
33. RhoB is frequently downregulated in non-small-cell lung cancer and resides in the 2p24 homozygous deletion region of a lung cancer cell line.
Sato N; Fukui T; Taniguchi T; Yokoyama T; Kondo M; Nagasaka T; Goto Y; Gao W; Ueda Y; Yokoi K; Minna JD; Osada H; Kondo Y; Sekido Y
Int J Cancer; 2007 Feb; 120(3):543-51. PubMed ID: 17096327
[TBL] [Abstract][Full Text] [Related]
34. Long Non-Coding RNA DUXAP8 Acts as an Oncogene in Sinonasal Squamous Cell Carcinoma Through miR-584-5p/FNDC3B Pathway.
Chen X; Li G; Zhong G; Chen J; Feng L; Zhang T; Tang Z
Am J Rhinol Allergy; 2022 Nov; 36(6):708-718. PubMed ID: 35695194
[TBL] [Abstract][Full Text] [Related]
35. Retraction Notice to: The Pseudogene DUXAP8 Promotes Non-small-cell Lung Cancer Cell Proliferation and Invasion by Epigenetically Silencing EGR1 and RHOB.
Sun M; Nie FQ; Zang C; Wang Y; Hou J; Wei C; Li W; He X; Lu KH
Mol Ther; 2024 Jun; ():. PubMed ID: 38857596
[No Abstract] [Full Text] [Related]
36. Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer.
Shi X; Liu Z; Liu Z; Feng X; Hua F; Hu X; Wang B; Lu K; Nie F
EBioMedicine; 2018 Nov; 37():177-187. PubMed ID: 30314898
[TBL] [Abstract][Full Text] [Related]
37. Long intergenic noncoding RNA 00673 promotes non-small-cell lung cancer metastasis by binding with EZH2 and causing epigenetic silencing of HOXA5.
Ma C; Wu G; Zhu Q; Liu H; Yao Y; Yuan D; Liu Y; Lv T; Song Y
Oncotarget; 2017 May; 8(20):32696-32705. PubMed ID: 28423732
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells.
Kikuchi J; Takashina T; Kinoshita I; Kikuchi E; Shimizu Y; Sakakibara-Konishi J; Oizumi S; Marquez VE; Nishimura M; Dosaka-Akita H
Lung Cancer; 2012 Nov; 78(2):138-43. PubMed ID: 22925699
[TBL] [Abstract][Full Text] [Related]
39. linc01088 promotes cell proliferation by scaffolding EZH2 and repressing p21 in human non-small cell lung cancer.
Liu JQ; Feng YH; Zeng S; Zhong MZ
Life Sci; 2020 Jan; 241():117134. PubMed ID: 31811854
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic regulation of RhoB loss of expression in lung cancer.
Mazières J; Tovar D; He B; Nieto-Acosta J; Marty-Detraves C; Clanet C; Pradines A; Jablons D; Favre G
BMC Cancer; 2007 Nov; 7():220. PubMed ID: 18047684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
